https://orcid.org/0000-0002-1488-2687
Citations (3)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Jingyan Yang, Shailja Vaghela, Benjamin Yarnoff, Solene De Boisvilliers, Manuela Di Fusco, Timothy Lee Wiemken, Moe H. Kyaw, John M. McLaughlin & Jennifer L. Nguyen. (2023) Estimated global public health and economic impact of COVID-19 vaccines in the pre-omicron era using real-world empirical data. Expert Review of Vaccines 22:1, pages 54-65.
Read now
Read now
Manuela Di Fusco, Kinga Marczell, Elizabeth Thoburn, Timothy L. Wiemken, Jingyan Yang & Benjamin Yarnoff. (2023) Public health impact and economic value of booster vaccination with Pfizer-BioNTech COVID-19 vaccine, bivalent (Original and Omicron BA.4/BA.5) in the United States. Journal of Medical Economics 26:1, pages 509-524.
Read now
Read now
Articles from other publishers (1)
Sarah E Vititoe, Priya Govil, Aidan Baglivo, Elisha Beebe, Elizabeth M Garry, Nicolle M Gatto, Tamar Lasky, Aloka Chakravarty, Marie C Bradley, Silvia Perez-Vilar, Donna R Rivera, Kenneth Quinto, Andrew Clerman, Anil Rajpal & Vera Frajzyngier. (2023) A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022. Open Forum Infectious Diseases 10:7.
Crossref
Crossref